Chemical SOP
Microbiology SOP
Warehouse SOP
Manufacturing SOP
Information technology SOP

Category PICTORIAL

Risk Assessment for APQR

Risk Assessment for APQR

Introduction The Annual Product Quality Review (APQR) is a critical quality management activity mandated by global regulatory authorities including the US FDA, EU GMP (Annex 15 & 16), WHO, and ICH Q10. The purpose of the APQR is to systematically…

Risk Assessment for Inefficient QA in Pharma

Risk Assessment for Inefficient QA in Pharma

Introduction: Quality Assurance (QA) is a foundational element of pharmaceutical manufacturing, responsible for establishing, monitoring, and enforcing systems that ensure product quality, safety, and regulatory compliance. QA functions encompass a wide range of activities, including documentation control, deviation management, batch…

Risk Assessment for Epoxy in Pharma

Risk Assessment for Epoxy in Pharma

Introduction: In pharmaceutical manufacturing environments, the selection and maintenance of flooring systems are critical to ensuring compliance with Good Manufacturing Practices (GMP). Epoxy flooring is widely used in cleanrooms, production areas, and packaging zones due to its seamless finish, chemical…

Risk Assessment for GMP Drains

Risk Assessment for GMP Drain

Introduction: Drains in pharmaceutical manufacturing areas play a crucial role in managing wastewater, preventing backflow, and maintaining sanitary conditions. However, if not properly designed, maintained, or monitored, GMP (Good Manufacturing Practice) drains can become significant sources of contamination—posing a risk…

Risk Assessment for Low Illumination in Visual Inspection area

Risk Assessment for Low Illumination in Visual Inspection area

Introduction: Visual inspection is a critical quality control process in pharmaceutical manufacturing, particularly for sterile and parenteral products. It relies heavily on the human ability to detect defects such as particulate matter, discoloration, improper filling, or sealing issues. Adequate illumination…

Risk Assessment for Typo Error in Pharma

Risk assessment for typo error in pharma

Typographical errors (typo errors) in the pharmaceutical industry, though often perceived as minor clerical mistakes, can lead to significant consequences affecting product quality, regulatory compliance, and patient safety. These errors may occur in a wide range of critical documents, including…

Risk Assessment for Data Integrity

Data Integrity

Data Integrity refers to the completeness, consistency, accuracy, and reliability of data throughout its lifecycle. In the pharmaceutical industry, data integrity is not just a regulatory requirement—it is the foundation of trust in pharmaceutical products. Regulatory agencies such as the…

Risk Assessment for Stability Samples not Charged

Risk Assessment for Stability Samples Not Charged

Failure to charge (place) stability samples as per the approved protocol is a significant GMP deviation that may compromise product shelf life justification and regulatory compliance. A structured risk assessment is essential to evaluate the impact and determine appropriate corrective…

Risk Assessment for AQL not performed

Risk Assessment for AQL not performed

Introduction: The Acceptable Quality Level (AQL) inspection is a critical component of the quality assurance process that determines whether a batch of product meets predefined acceptance criteria before release or further processing. Failure to perform AQL inspection can result in…

Risk Assessment for Terminal Sterilization of Ampoules

Risk Assessment for Terminal Sterilization of Ampoules

Terminal sterilization is a critical process in pharmaceutical manufacturing where the final product, in its sealed primary container (e.g., ampoule, vial, syringe), is subjected to a sterilization method to ensure the complete destruction of viable microorganisms. It is considered the…

error: Content is protected !!

This is the Premium Content

You can access this page after paying the subscription fees of 21 ₹ /month only.